November 13 • 1:30 p.m.

Personalized Medicine: A Global Endeavor

On November 13, All of Us Research Program CEO Joshua C. Denny, M.D., and European Partnership for Personalised Medicine Support Leader Monika Frenzel, Ph.D., will take the stage at Harvard Medical School during the Annual Personalized Medicine Conference to make the case for personalized medicine as a national and regional priority for the United States and Europe.

During their discussion with moderator, PMC Board Member, and European Infrastructure for Translational Medicine Scientific Director Antonio Andreu, M.D., Ph.D., Drs. Denny and Frenzel will reflect on the opportunities and challenges facing the flagship personalized medicine programs in the United States and Europe. Denny and Frenzel will also answer questions from the conference audience, which will include leading investors, journalists, and researchers, among other participants.

The discussion promises to shape thinking about the future of personalized medicine and public investments in biomedical research for years to come.

  • Moderator

    Antonio L. Andreu, M.D., Ph.D.
    Scientific Director, European Infrastructure for Translational Medicine

  • Speaker

    Joshua C. Denny, M.D., M.S.
    CEO, All of Us Research Program , U.S. National Institutes of Health

  • Speaker

    Monika Frenzel, Ph.D.
    Research Funding and Support Leader, European Partnership for Personalised Medicine